Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Bokemeyer

Showing results (481-490 of 664) with videos related to

Pageof 67
Sort By:
Oncology|February 24, 2006
Independent risk factors for anemia in cancer patients receiving chemotherapy: results from the European Cancer Anaemia SurveyPeter J Barrett-Lee, Heinz Ludwig, Gunnar Birgegård, et al.
European Radiology|November 20, 2023
Long-term cardiotoxicity in germ cell cancer survivors after platinum-based chemotherapy: cardiac MR shows impaired systolic function and tissue alterationsAntonia Beitzen-Heineke, Christina Charlotte Rolling, Christoph Seidel, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|May 15, 2020
Onco-Cardiology: Consensus Paper of the German Cardiac Society, the German Society for Pediatric Cardiology and Congenital Heart Defects and the German Society for Hematology and Medical OncologyTienush Rassaf, Matthias Totzeck, Johannes Backs, et al.
Human Pathology|December 20, 2005
Maturation delay of germ cells in fetuses with trisomy 21 results in increased risk for the development of testicular germ cell tumorsMartine Cools, Friedemann Honecker, Hans Stoop, et al.
Haematologica|May 25, 2011
Surface molecule CD229 as a novel target for the diagnosis and treatment of multiple myelomaDjordje Atanackovic, Jens Panse, York Hildebrandt, et al.
The Prostate|September 3, 2010
High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancerSarah Minner, Corinna Wittmer, Markus Graefen, et al.
Marine Drugs|January 22, 2024
Anticancer Activity of the Marine Triterpene Glycoside Cucumarioside A<sub>2</sub>-2 in Human Prostate Cancer CellsEkaterina S Menchinskaya, Sergey A Dyshlovoy, Simone Venz, et al.
Anti-Cancer Drugs|May 29, 2004
Prospective multicenter phase II study of irinotecan as third-line therapy in metastatic colorectal cancer and progression after bolus and infusional 5-fluorouracilJoerg Thomas Hartmann, Karin Oechsle, Elke Jäger, et al.
Oncoimmunology|May 13, 2024
Expression of CD39 is associated with T cell exhaustion in ovarian cancer and its blockade reverts T cell dysfunctionMarius Witt, Leticia Oliveira-Ferrer, Friedrich Koch-Nolte, et al.
Plos One|February 25, 2011
Identification of clinically relevant protein targets in prostate cancer with 2D-DIGE coupled mass spectrometry and systems biology network platformRamesh Ummanni, Frederike Mundt, Heike Pospisil, et al.
Pageof 67

Showing results (481-490 of 664) with videos related to

Sort By:
Pageof 67
Oncology|February 24, 2006
Independent risk factors for anemia in cancer patients receiving chemotherapy: results from the European Cancer Anaemia SurveyPeter J Barrett-Lee, Heinz Ludwig, Gunnar Birgegård, et al.
European Radiology|November 20, 2023
Long-term cardiotoxicity in germ cell cancer survivors after platinum-based chemotherapy: cardiac MR shows impaired systolic function and tissue alterationsAntonia Beitzen-Heineke, Christina Charlotte Rolling, Christoph Seidel, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|May 15, 2020
Onco-Cardiology: Consensus Paper of the German Cardiac Society, the German Society for Pediatric Cardiology and Congenital Heart Defects and the German Society for Hematology and Medical OncologyTienush Rassaf, Matthias Totzeck, Johannes Backs, et al.
Human Pathology|December 20, 2005
Maturation delay of germ cells in fetuses with trisomy 21 results in increased risk for the development of testicular germ cell tumorsMartine Cools, Friedemann Honecker, Hans Stoop, et al.
Haematologica|May 25, 2011
Surface molecule CD229 as a novel target for the diagnosis and treatment of multiple myelomaDjordje Atanackovic, Jens Panse, York Hildebrandt, et al.
The Prostate|September 3, 2010
High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancerSarah Minner, Corinna Wittmer, Markus Graefen, et al.
Marine Drugs|January 22, 2024
Anticancer Activity of the Marine Triterpene Glycoside Cucumarioside A<sub>2</sub>-2 in Human Prostate Cancer CellsEkaterina S Menchinskaya, Sergey A Dyshlovoy, Simone Venz, et al.
Anti-Cancer Drugs|May 29, 2004
Prospective multicenter phase II study of irinotecan as third-line therapy in metastatic colorectal cancer and progression after bolus and infusional 5-fluorouracilJoerg Thomas Hartmann, Karin Oechsle, Elke Jäger, et al.
Oncoimmunology|May 13, 2024
Expression of CD39 is associated with T cell exhaustion in ovarian cancer and its blockade reverts T cell dysfunctionMarius Witt, Leticia Oliveira-Ferrer, Friedrich Koch-Nolte, et al.
Plos One|February 25, 2011
Identification of clinically relevant protein targets in prostate cancer with 2D-DIGE coupled mass spectrometry and systems biology network platformRamesh Ummanni, Frederike Mundt, Heike Pospisil, et al.
Pageof 67